Remove 2019 Remove Analytical Chemistry Remove Licensing Remove Small Molecule
article thumbnail

BioSpace Movers & Shakers, Nov. 6

The Pharma Data

Prior to joining Imperative Care in 2019, Davis served as chief commercial officer and president of North America at Penumbra, Inc., Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007.